Mazurek M, Jaros M, Gliwa A, Sitarz M, Dudzinska E, Zinkiewicz K
Int J Mol Sci. 2025; 26(2).
PMID: 39859425
PMC: 11765604.
DOI: 10.3390/ijms26020711.
Solares S, Leon J, Garcia-Gutierrez L
Cancers (Basel). 2025; 16(24.
PMID: 39766110
PMC: 11674381.
DOI: 10.3390/cancers16244212.
Corallo S, Lasagna A, Filippi B, Alaimo D, Tortorella A, Serra F
Pathogens. 2024; 13(9).
PMID: 39338919
PMC: 11435077.
DOI: 10.3390/pathogens13090728.
He S, Luo C, Shi F, Zhou J, Shang L
Biology (Basel). 2024; 13(7).
PMID: 39056735
PMC: 11274159.
DOI: 10.3390/biology13070543.
Bringeland E, Vage C, Uboe A, Sando A, Mjones P, Fossmark R
Cancers (Basel). 2024; 16(11).
PMID: 38893119
PMC: 11170983.
DOI: 10.3390/cancers16112000.
Epstein-Barr virus positive gastric cancer: the pathological basis of CT findings and radiomics models prediction.
Sun S, Li L, Xu M, Wei Y, Shi F, Liu S
Abdom Radiol (NY). 2024; 49(6):1779-1791.
PMID: 38656367
DOI: 10.1007/s00261-024-04306-8.
The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape.
Salnikov M, MacNeil K, Mymryk J
Front Immunol. 2024; 15:1358511.
PMID: 38596668
PMC: 11002251.
DOI: 10.3389/fimmu.2024.1358511.
Targeting latent viral infection in EBV-associated lymphomas.
Kong I, Giulino-Roth L
Front Immunol. 2024; 15:1342455.
PMID: 38464537
PMC: 10920267.
DOI: 10.3389/fimmu.2024.1342455.
Integrated environmental, lifestyle, and epigenetic risk prediction of primary gastric neoplasia using the longitudinally monitored cohorts.
Usui G, Matsusaka K, Huang K, Zhu F, Shinozaki T, Fukuyo M
EBioMedicine. 2024; 98:104844.
PMID: 38251469
PMC: 10755115.
DOI: 10.1016/j.ebiom.2023.104844.
Unusual or Uncommon Histology of Gastric Cancer.
Shin J, Park Y
J Gastric Cancer. 2024; 24(1):69-88.
PMID: 38225767
PMC: 10774758.
DOI: 10.5230/jgc.2024.24.e7.
Identification and characterization of the anti-viral interferon lambda 3 as direct target of the Epstein-Barr virus microRNA-BART7-3p.
Blumke J, Bauer M, Vaxevanis C, Wilfer A, Mandelboim O, Wickenhauser C
Oncoimmunology. 2023; 12(1):2284483.
PMID: 38126030
PMC: 10732682.
DOI: 10.1080/2162402X.2023.2284483.
Endoscopic Diagnosis and Therapy for Epstein-Barr Virus-Associated Gastric Cancer.
Yanai H, Fujiwara J, Toyama E, Okuda H, Miura O, Kaino S
Microorganisms. 2023; 11(11).
PMID: 38004633
PMC: 10673609.
DOI: 10.3390/microorganisms11112619.
EBV antibody and gastric cancer risk: a population-based nested case-control study in southern China.
Du Y, Yu X, Chang E, Yin L, Lian S, Wu B
BMC Cancer. 2023; 23(1):521.
PMID: 37291490
PMC: 10251656.
DOI: 10.1186/s12885-023-10994-0.
Epstein-Barr virus: the molecular virology and the associated diseases.
Murata T
Fujita Med J. 2023; 9(2):65-72.
PMID: 37234394
PMC: 10206890.
DOI: 10.20407/fmj.2022-018.
Epstein-Barr Virus History and Pathogenesis.
Yu H, Robertson E
Viruses. 2023; 15(3).
PMID: 36992423
PMC: 10056551.
DOI: 10.3390/v15030714.
Quantitative analysis of Epstein-Barr virus DNA in plasma and stomach biopsies of patients with gastric cancer.
Sarshari B, Ravanshad M, Rabbani A, Zareh-Khoshchehreh R, Mokhtari F, Khanabadi B
Virus Genes. 2023; 59(3):351-358.
PMID: 36757510
DOI: 10.1007/s11262-023-01977-1.
Characterization of a new CCCTC-binding factor binding site as a dual regulator of Epstein-Barr virus latent infection.
Lee S, Kim K, Cho M, Huh S, An S, Seo D
PLoS Pathog. 2023; 19(1):e1011078.
PMID: 36696451
PMC: 9876287.
DOI: 10.1371/journal.ppat.1011078.
Tumor-Infiltrating T Cells in EBV-Associated Gastric Carcinomas Exhibit High Levels of Multiple Markers of Activation, Effector Gene Expression, and Exhaustion.
Salnikov M, Prusinkiewicz M, Lin S, Ghasemi F, Cecchini M, Mymryk J
Viruses. 2023; 15(1).
PMID: 36680216
PMC: 9860965.
DOI: 10.3390/v15010176.
Epstein-Barr Virus Regulates Endothelin-1 Expression through the ERK/FOXO1 Pathway in EBV-Associated Gastric Cancer.
Liu W, Zhang Q, Zhang Y, Sun L, Xiao H, Luo B
Microbiol Spectr. 2022; 11(1):e0089822.
PMID: 36475746
PMC: 9927292.
DOI: 10.1128/spectrum.00898-22.
Epstein-Barr virus detection in endoscopic submucosal dissection-proven early gastric cancer with mixed-type histology.
Yanai H, Chihara D, Harano M, Sakaguchi E, Kaino S, Murakami T
Cancer Rep (Hoboken). 2022; 6(5):e1730.
PMID: 36421012
PMC: 10172166.
DOI: 10.1002/cnr2.1730.